Title:
【発明の名称】ヘパリン含有製剤
Document Type and Number:
Japanese Patent JP2783367
Kind Code:
B2
Abstract:
The formulations, typically for intravenous administration in the therapeutic treatment of thrombotic events, comprise an endo-beta-glucuronidase (typically leech-derived) and heparin, and, optionally, a clot-lytic agent (such as tissue plasminogen activator). Endo-beta-glucuronidases, unlike other hyaluronidases, have been found to be not inhibited by heparin.
Inventors:
SOIYAA ROI
PAUERU JOONZU KURISUTOFUAA
PAUERU JOONZU KURISUTOFUAA
Application Number:
JP50455689A
Publication Date:
August 06, 1998
Filing Date:
April 14, 1989
Export Citation:
Assignee:
MERUTSUKU PATENTO GMBH
International Classes:
A61K38/46; A61K31/715; A61K38/47; A61K38/49; A61K38/58; A61P7/02; (IPC1-7): A61K38/46; A61K31/725
Attorney, Agent or Firm:
Akira Asamura (3 outside)